Recordati Industria Chimica e Farmaceutica Competitors

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Bank of Communications (OTCMKTS:BCMXY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Bank of Communications' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Bank of Communications, as reported by MarketBeat.

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Bank of Communications' gross revenue, earnings per share (EPS) and valuation.

Bank of Communications has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica.

Risk & Volatility

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, Bank of Communications has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Henkel AG & Co. KGaA (OTCMKTS:HENKY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

0.1% of Henkel AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Henkel AG & Co. KGaA's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Henkel AG & Co. KGaA, as reported by MarketBeat.

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Henkel AG & Co. KGaA's gross revenue, earnings per share (EPS) and valuation.

Henkel AG & Co. KGaA has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica. Henkel AG & Co. KGaA is trading at a lower price-to-earnings ratio than Recordati Industria Chimica e Farmaceutica, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Henkel AG & Co. KGaA has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

0.2% of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, as reported by MarketBeat.

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München's gross revenue, earnings per share (EPS) and valuation.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Summary

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München beats Recordati Industria Chimica e Farmaceutica on 7 of the 11 factors compared between the two stocks.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and Sun Hung Kai Properties (OTCMKTS:SUHJY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Insider & Institutional Ownership

0.1% of Sun Hung Kai Properties shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and Sun Hung Kai Properties' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and Sun Hung Kai Properties, as reported by MarketBeat.

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and Sun Hung Kai Properties' gross revenue, earnings per share (EPS) and valuation.

Sun Hung Kai Properties has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica. Sun Hung Kai Properties is trading at a lower price-to-earnings ratio than Recordati Industria Chimica e Farmaceutica, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Sun Hung Kai Properties has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and The Swatch Group (OTCMKTS:SWGAY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and The Swatch Group's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and The Swatch Group, as reported by MarketBeat.

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and The Swatch Group's gross revenue, earnings per share (EPS) and valuation.

The Swatch Group has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica.

Risk & Volatility

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, The Swatch Group has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.

Summary

The Swatch Group beats Recordati Industria Chimica e Farmaceutica on 5 of the 9 factors compared between the two stocks.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) and SMC (OTCMKTS:SMCAY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Recordati Industria Chimica e Farmaceutica and SMC's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and target prices for Recordati Industria Chimica e Farmaceutica and SMC, as reported by MarketBeat.

Insider & Institutional Ownership

0.8% of SMC shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility and Risk

Recordati Industria Chimica e Farmaceutica has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, SMC has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.

Earnings & Valuation

This table compares Recordati Industria Chimica e Farmaceutica and SMC's gross revenue, earnings per share (EPS) and valuation.

SMC has higher revenue and earnings than Recordati Industria Chimica e Farmaceutica. Recordati Industria Chimica e Farmaceutica is trading at a lower price-to-earnings ratio than SMC, indicating that it is currently the more affordable of the two stocks.

Summary

SMC beats Recordati Industria Chimica e Farmaceutica on 8 of the 12 factors compared between the two stocks.